Adma Biologics, Inc.
ADMA· Nasdaq
Released Mar 9, 2015, after the close
10-K filed Mar 9, 2015, 68 days after period end · 0001193805-15-000352
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011 |
|---|---|---|---|---|
| Revenue | $1.49M | $424.03K | $523.28K | — |
| Net Income | -$3.56M | -$4.70M | -$2.25M | -$8.33K |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| EPS Diluted | — | — | — | $0.00 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.